Pharmacology advances in the neuroscience intensive care unit.
New drugs are continuously being developed to enhance care in the neuro ICU. Newer drugs with special implications for the neurologically impaired population include fosphenytoin, tissue plasminogen activator, and propofol. Nurses are challenged to use these drugs in a safe and effective manner.
Stewart-Amidei
Chris
C
Section of Neurosurgery, University of Chicago, Illinois 60637, USA. camidei@aol.com
D000927:Anticonvulsants / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D003422:Critical Care; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007362:Intensive Care Units; D009488:Neurosciences / Q000639:trends; D009732:Nursing Care; D010672:Phenytoin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D015742:Propofol / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D012640:Seizures / Q000188:drug therapy* / Q000517:prevention & control; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use
D000927:Anticonvulsants; D005343:Fibrinolytic Agents; D010672:Phenytoin; C043114:fosphenytoin; D010959:Tissue Plasminogen Activator; D015742:Propofol